KEYTRUDA ®( Pembrolizumab) Clinical Trials
4 recruitingDrug
Phase 14Phase 21
Showing 1–4 of 4 trials
Recruiting
Phase 1
A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma
Advanced Urothelial CarcinomaOral Drug AdministrationOpen Label
Flare Therapeutics Inc.120 enrolled11 locationsNCT05929235
Recruiting
Phase 1
Study of HC006 in Combination With a PD-1 Inhibitor in Patients With Advanced Solid Tumors
Advanced Cancer
HC Biopharma Inc.252 enrolled1 locationNCT06963814
Recruiting
Phase 1
A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of ATG 037 Monotherapy and Combination Therapy With Pembrolizumab in Patients With Advanced Solid Tumors
Locally Advanced or Metastatic Solid Tumors
Antengene Therapeutics Limited98 enrolled7 locationsNCT05205109
Recruiting
Phase 1Phase 2
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
CancerCutaneous MelanomaMelanoma Stage IV+1 more
Krystal Biotech, Inc.240 enrolled15 locationsNCT05970497